Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects

Am J Clin Nutr. 1999 Jun;69(6):1135-43. doi: 10.1093/ajcn/69.6.1135.

Abstract

Background: Elevations of postprandial triacylglycerol-rich plasma lipoproteins and suppressions of HDL-cholesterol concentrations are considered potentially atherogenic. Long-term studies have shown beneficial effects of monounsaturated fatty acids (eg, oleic acid) on fasting lipid and lipoprotein concentrations in humans. A direct stimulatory effect of oleic acid on the secretion of glucagon-like peptide 1 (GLP-1) was shown in animal studies.

Objective: We compared the postprandial responses of glucose, insulin, fatty acids, triacylglycerol, gastric inhibitory polypeptide (GIP), and GLP-1 to test meals rich in saturated and monounsaturated fatty acids.

Design: Ten young, lean, healthy persons ingested 3 meals: an energy-free soup consumed with 50 g carbohydrate (control meal), the control meal plus 100 g butter, and the control meal plus 80 g olive oil. Triacylglycerol and retinyl palmitate responses were measured in total plasma, in a chylomicron-rich fraction, and in a chylomicron-poor fraction.

Results: No significant differences in glucose, insulin, or fatty acid responses to the 2 fat-rich meals were seen. Plasma triacylglycerol responses were highest after the butter meal, with chylomicron triacylglycerol rising 2.5-5-fold. Retinyl palmitate responses were higher and more prolonged after the butter meal than after the control and olive oil meals, whereas both postprandial HDL-cholesterol concentrations and GLP-1 and GIP responses were higher after the olive oil meal than after the butter meal.

Conclusions: Olive oil induced lower triacylglycerol concentrations and higher HDL-cholesterol concentrations than butter, without eliciting differences in concentrations of glucose, insulin, or fatty acids. Furthermore, olive oil induced higher concentrations of GLP-1 and GIP than did butter, which may point to a relation between fatty acid composition, incretin responses, and triacylglycerol metabolism in the postprandial phase.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose / drug effects
  • Butter
  • Cholesterol, HDL / blood*
  • Diet
  • Dietary Fats / administration & dosage
  • Dietary Fats / pharmacology*
  • Fatty Acids / administration & dosage
  • Fatty Acids / blood
  • Fatty Acids / pharmacology*
  • Fatty Acids, Monounsaturated / administration & dosage
  • Fatty Acids, Monounsaturated / blood
  • Fatty Acids, Monounsaturated / pharmacology*
  • Female
  • Gastric Inhibitory Polypeptide / blood
  • Glucagon
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptides
  • Humans
  • Insulin / blood
  • Male
  • Neurotransmitter Agents / blood*
  • Olive Oil
  • Peptide Fragments / blood*
  • Peptides / blood
  • Plant Oils
  • Postprandial Period*
  • Triglycerides / blood*

Substances

  • Blood Glucose
  • Cholesterol, HDL
  • Dietary Fats
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Insulin
  • Neurotransmitter Agents
  • Olive Oil
  • Peptide Fragments
  • Peptides
  • Plant Oils
  • Triglycerides
  • glucagon-like peptide 1 (7-36)amide
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptides
  • Butter
  • Glucagon-Like Peptide 1
  • Glucagon